Abiopharma

Director Fung Peter K 🟢 acquired 2.3K shares (1 derivative) of Cardio Diagnostics Holdings, Inc. (CDIO) at $2.71 Transaction Date: Dec 31, 2025 | Filing ID: 000001

Director Betts Wendy J 🟢 acquired 2.3K shares (1 derivative) of Cardio Diagnostics Holdings, Inc. (CDIO) at $2.71 Transaction Date: Dec 31, 2025 | Filing ID: 000001

Director Intrater James 🟢 acquired 2.3K shares (1 derivative) of Cardio Diagnostics Holdings, Inc. (CDIO) at $2.71 Transaction Date: Dec 31, 2025 | Filing ID: 000001

Director Burton Paul Frederick 🟢 acquired 2.3K shares (1 derivative) of Cardio Diagnostics Holdings, Inc. (CDIO) at $2.71 Transaction Date: Dec 31, 2025 | Filing ID: 000001

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement

Xreal Air 2 Pro: Latest Info and Updates

New Form 424B5 - Estrella Immunopharma, Inc. Filed: 2026-01-06 AccNo: 0001213900-26-001686 Size: 356 KB

Why Is Fortnite Not Working? Troubleshooting Steps To Try

(85% Positive) PROFOUND MEDICAL CORP. (PROF) Provides Update on advancement for prostate care

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit

(70% Positive) AIxCrypto Holdings, Inc. (QLGN) Announces Business Combination

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit

Alvotech (ALVOW) Files Form 6-K